JP2023538278A5 - - Google Patents

Info

Publication number
JP2023538278A5
JP2023538278A5 JP2023507920A JP2023507920A JP2023538278A5 JP 2023538278 A5 JP2023538278 A5 JP 2023538278A5 JP 2023507920 A JP2023507920 A JP 2023507920A JP 2023507920 A JP2023507920 A JP 2023507920A JP 2023538278 A5 JP2023538278 A5 JP 2023538278A5
Authority
JP
Japan
Application number
JP2023507920A
Other languages
Japanese (ja)
Other versions
JPWO2022031956A5 (https=
JP2023538278A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/044719 external-priority patent/WO2022031956A1/en
Publication of JP2023538278A publication Critical patent/JP2023538278A/ja
Publication of JPWO2022031956A5 publication Critical patent/JPWO2022031956A5/ja
Publication of JP2023538278A5 publication Critical patent/JP2023538278A5/ja
Pending legal-status Critical Current

Links

JP2023507920A 2020-08-05 2021-08-05 中等度から重度の喘息の治療におけるデクスプラミペキソールの使用 Pending JP2023538278A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202063061226P 2020-08-05 2020-08-05
US63/061,226 2020-08-05
US202163136933P 2021-01-13 2021-01-13
US63/136,933 2021-01-13
US202163147024P 2021-02-08 2021-02-08
US63/147,024 2021-02-08
US202163174938P 2021-04-14 2021-04-14
US63/174,938 2021-04-14
PCT/US2021/044719 WO2022031956A1 (en) 2020-08-05 2021-08-05 Use of dexpramipexole for the treatment of moderate to severe asthma

Publications (3)

Publication Number Publication Date
JP2023538278A JP2023538278A (ja) 2023-09-07
JPWO2022031956A5 JPWO2022031956A5 (https=) 2024-08-13
JP2023538278A5 true JP2023538278A5 (https=) 2024-08-13

Family

ID=80115688

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023507920A Pending JP2023538278A (ja) 2020-08-05 2021-08-05 中等度から重度の喘息の治療におけるデクスプラミペキソールの使用

Country Status (11)

Country Link
US (4) US20220040154A1 (https=)
EP (1) EP4192453A4 (https=)
JP (1) JP2023538278A (https=)
KR (1) KR20230067604A (https=)
CN (1) CN116419746A (https=)
AU (1) AU2021322255A1 (https=)
CA (1) CA3186844A1 (https=)
CL (1) CL2023000296A1 (https=)
IL (1) IL300357A (https=)
MX (1) MX2023001140A (https=)
WO (1) WO2022031956A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115260119B (zh) * 2022-07-26 2023-02-10 山东京卫制药有限公司 一种普拉克索昔萘酸盐及其药物缓释制剂
KR20250001767A (ko) 2023-06-29 2025-01-07 재단법인 아산사회복지재단 천식의 분류를 위한 바이오마커 및 이의 용도
WO2025137498A1 (en) * 2023-12-20 2025-06-26 Areteia Therapeutics, Inc. Matrix tablets of dexpramipexole and methods of manufacturing and use thereof
US20250205206A1 (en) * 2023-12-20 2025-06-26 Areteia Therapeutics, Inc. Use of dexpramipexole for the treatment of inadequately controlled moderate to severe asthma
WO2025240942A1 (en) * 2024-05-17 2025-11-20 Areteia Therapeutics, Inc. Use of dexpramipexole for the treatment of eosinophilic copd

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1730129B1 (en) * 2004-03-19 2011-01-19 Dipharma Francis S.r.l. Intermediates for the preparation of pramipexole
WO2009120927A2 (en) * 2008-03-28 2009-10-01 Smithkline Beecham Corporation Methods of treatment
WO2013034173A1 (en) * 2011-09-06 2013-03-14 Synthon Bv Pramipexole extended release tablets
EP3838271B1 (en) * 2013-07-12 2025-09-03 Areteia Therapeutics, Inc. Treating elevated levels of eosinophils and/or basophils
US9468630B2 (en) * 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
IL315136A (en) * 2014-02-21 2024-10-01 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4rantagonist
WO2017197360A1 (en) * 2016-05-13 2017-11-16 The Regents Of The University Of California Airway mucus impaction

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
JP2023538278A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)